Page last updated: 2024-10-22

amitriptyline and Degenerative Diseases, Central Nervous System

amitriptyline has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kwon, Y1
Bang, Y1
Moon, SH1
Kim, A1
Choi, HJ1
Paumier, KL1
Sortwell, CE1
Madhavan, L1
Terpstra, B1
Celano, SL1
Green, JJ1
Imus, NM1
Marckini, N1
Daley, B1
Steece-Collier, K1
Collier, TJ1

Other Studies

2 other studies available for amitriptyline and Degenerative Diseases, Central Nervous System

ArticleYear
Amitriptyline interferes with autophagy-mediated clearance of protein aggregates via inhibiting autophagosome maturation in neuronal cells.
    Cell death & disease, 2020, 10-17, Volume: 11, Issue:10

    Topics: Amitriptyline; Animals; Autophagosomes; Autophagy; Depressive Disorder, Major; Lysosomes; Neurodegen

2020
Chronic amitriptyline treatment attenuates nigrostriatal degeneration and significantly alters trophic support in a rat model of parkinsonism.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:4

    Topics: Adrenergic Agents; Amitriptyline; Analgesics, Non-Narcotic; Animals; Brain-Derived Neurotrophic Fact

2015